1. Introduction {#sec1}
===============

Depression has been recognized as an independent predictor for the development of coronary heart disease (CHD) among healthy and, especially, elderly individuals. Rugulies \[[@B1]\], in a recent meta-analysis, reported that depression increases the risk of myocardial infarction (MI) and coronary death, while that risk is not limited to patients with clinical depression. Similarly, in patients recovering from an acute coronary syndrome (ACS), even the presence of mildly elevated depressive symptoms is associated with a worse prognosis \[[@B2]\]. Additionally, a linear association seems to exist between the occurrence of depressive symptomatology at the time of an MI and the risk of subsequent cardiac morbidity and mortality \[[@B3], [@B4]\].

During the past 30 years, several observational studies and clinical trials have provided scientific evidence that the Mediterranean diet is associated with decreased all-cause mortality and improvements in cardiovascular risk factors levels \[[@B5], [@B6]\]. From the late 1960s, Keys and his colleagues from the Seven Countries study underlined the effect of the dietary habits observed in Mediterranean populations on cardiovascular disease risk \[[@B7]\]. De Lorgeril et al., from the Lyon Heart Study, that was a randomized secondary prevention clinical trial of CHD patients, revealed the protective effect of this traditional dietary pattern on cardiac complications of the patients within the first 27 months of followup after an acute coronary event \[[@B8]\]. A more recent study in ACS patients illustrated that greater adherence to the Mediterranean diet seems to preserve left ventricular systolic function and is associated with better long-term prognosis of \[[@B9]\].

Although it is generally accepted that depression is independently associated with a worse cardiac prognosis, controversy persists whether this association is a reflection of cardiac disease severity, as some studies have reported significant univariate associations, but have failed to find a significant relationship after adjustment for markers of cardiac disease severity \[[@B11], [@B12]\]. Furthermore, other protective lifestyle factors may play a mediator role in the effect of depressive symptomatology on clinical outcome. Among those lifestyle factors, healthy dietary habits due to their anti-inflammatory and antioxidative properties have revealed cardioprotective effect \[[@B8], [@B9]\]. Finally, it is well known that the elderly represent the fastest growing segment of the population. In addition, although it is widely adopted that the risk for CVD is an exponential function of age, because of various functional changes observed, the rate of these changes varies greatly among elderly individuals. The relationship between depression and cardiovascular health may also be attributed to lifelong behavioral and lifestyle.

The purpose of this work was to evaluate the role of short-term depressive symptoms in relation to dietary habits on the short-term (i.e., 30-day) clinical outcome of elderly patients who survived ACS.

2. Methods {#sec2}
==========

2.1. Study\'s Sample {#sec2.1}
--------------------

From May 2006 to March 2009, 1000 of the 1257 consecutive patients who were hospitalised in our Institution for an ACS (first or recurrent) were enrolled in the study (participation rate 80%); nonparticipants were patients who denied to provide the requested information or died during the first 48 hours of hospitalization. For the present analysis, 277 elderly (i.e., \>65 years) patients (75 ± 6 years, 70% males, 70% had a diagnosis of myocardial infarction) that gave the requested information regarding psychological evaluation were studied.

2.2. Bioethics {#sec2.2}
--------------

The study was approved by the Medical Research Ethics Committee of our Institution and was carried out in accordance with the Declaration of Helsinki (1989) of the World Medical Association. All patients were informed about the aims and procedures of the Study and gave their consent to participate.

2.3. Diagnosis of ACS {#sec2.3}
---------------------

At entry, a 12-lead electrocardiogram was performed and clinical symptoms were evaluated in all patients by a cardiologist. Moreover, blood tests were performed to detect evidence of myocardial cell death (i.e., Troponin I and the MB fraction of total creatinine phosphokinase (CPK)). As mentioned above, the study\'s sample included only cases with diagnoses of ACS (i.e., acute myocardial infarction (MI) or unstable angina (UA)). Acute MI was defined according to the latest guidelines \[[@B13]\] based on ECG findings and the aforementioned blood tests. Additionally, unstable angina was defined by the occurrence of one or more angina episodes, at rest, within the preceding 48-hours, corresponding to class III of the Braunwald classification \[[@B14]\].

2.4. Clinical and Biochemical Measurements {#sec2.4}
------------------------------------------

A detailed medical history was recorded, including (i) previous hospitalization for CVD (coronary heart disease or stroke), (ii) history and management of hypertension (defined as systolic or/and diastolic blood pressure \>140/90 mmHg or use of antihypertensive medication), (iii) hypercholesterolemia (defined as fasting serum total cholesterol \>200 mg/dL or use of lipid lowering agents), and (iv) diabetes mellitus (defined as fasting glucose \>125 mg/dL or use of special treatment), as well as patients\' medical family history of CVD. Furthermore the clinical course of all patients during hospitalization was recorded, including coronary angiography results and number of coronary vessels involved, thrombolysis, type of revascularization (primary angioplasty, coronary artery by-bass grafting), and time delay from the onset of symptoms to the arrival at the hospital.

In addition to the clinical information, white blood cell counts, uric acid, and brain natriuretic peptide (BNP) were measured at the time of hospital admission. BNP was determined by an enzyme-linked immunosorbent assay (Biomedica, Vienna, Austria), with inter- and intra-assay coefficients of variation being \<5% and with normal range of 0--100 pg/mL. Total cholesterol, high-density lipoprotein cholesterol, blood glucose, and triglycerides were also measured in all participants at the time of hospital admission using colorimetric enzymic method in a Technicon automatic analyzer RA-1000 (Dade-Behring Marburg GmbH, Marburg, Germany). Low-density lipoprotein cholesterol was calculated using the Friedewald formula: total cholesterol---HDL cholesterol---1/5 X (triglycerides). An internal quality control was in place for assessing the validity of cholesterol and triglycerides methods. The intra- and interassay coefficients of variation of cholesterol and triglycerides levels did not exceed 4%. Renal function was evaluated using the baseline creatinine clearance rate (CrCl) that was calculated using the Cockcroft-Gault formula: CrCl = \[\[(140 − age) × weight\]/(72 × serum creatinine)\] for men, while for women, the result of the above equation was multiplied by 0.85. A Roche/Hitachi Modular analyzer was used (Roche Diagnostics, Manheim, Germany) for all biochemical measurements. The biochemical evaluation was carried out in the same laboratory that followed the criteria of the World Health Organization Lipid Reference Laboratories. Samples were immediately processed for the determination of all biochemical parameters.

2.5. Demographic, Anthropometric, and Lifestyle Characteristics {#sec2.5}
---------------------------------------------------------------

Sociodemographic characteristics included age and sex. Height and weight were measured to the nearest 0.5 cm and 100 g, respectively. Body mass index (BMI) was calculated as weight (in kilograms) divided by height (in meters) squared. Obesity was defined as BMI greater than or equal to 30 kg/m^2^. To evaluate physical activity status of the patients during the past year, a modified version of a self-reported questionnaire provided by the American College of Sports Medicine was used \[[@B15]\]. Based on this questionnaire, the frequency (times per week), duration (in minutes per time) and intensity of sports or occupation-related physical activity were evaluated. Patients who did not report any physical activities were defined as sedentary. Current smokers were defined as those who smoked at least one cigarette per day or have stopped cigarette smoking during the past 12 months. Former smokers were defined as those who had stopped smoking more than one year previously. The rest of the patients were defined as never smokers or rare smokers.

2.6. Dietary Assessment and Evaluation of Adherence to the Mediterranean Diet {#sec2.6}
-----------------------------------------------------------------------------

The dietary evaluation took place after the third day of hospitalization. Usual dietary intake over the year preceding hospitalization was assessed in all patients by a validated, semiquantitative food frequency questionnaire \[[@B16]\]. The questionnaire included 75 items (i.e., foods and beverages commonly consumed in Greece, as well as dietary habits). Portion sizes were included in the food frequency questionnaire to assist patients to report accurate information and to quantify dietary habits. Alcohol consumption was measured in wineglasses (100 mL) and quantified by ethanol intake (grams per drink). One wineglass was equal to 12 g ethanol concentration. The MedDietScore was calculated for each participant in order to evaluate the level of adherence to the Mediterranean diet. In particular, intake of 10 food groups was evaluated (i.e., nonrefined cereals and products, fruits and nuts, vegetables, olive oil, dairy, fish, poultry, potatoes, pulses, red meat or meat products, and eggs), as well as alcohol drinking. The diet score was calculated as follows: for the consumption of items presumed to be close to the Mediterranean pattern (i.e., nonrefined cereals and products, fruits and nuts, vegetables, olive oil, non-fat or low fat dairy, fish, potatoes and pulses), score 0 was assigned when a patient reported no consumption, 1 when reported consumption of 1 to 4 times/month, 2 for 5 to 8 times/month, 3 for 9 to 12 times/month, 4 for 13 to 18 times/month, and 5 for more than 18 times per month. For the consumption of foods presumed to be away from this diet (like meat or meat products, eggs, poultry, and dairy), reverse scores were assigned (i.e., 0 when a patient reported almost daily consumption to 5 for rare or no consumption). Regarding alcohol intake, score 5 was assigned for consumption of less than 3 wineglasses per day, 0 for none or consumption of more than 7 wineglasses per day, and scores of 4, 3, 2, and 1 for the consumption of 3, 4-5, 6, and 7 wineglasses, respectively. This nonmonotonic scoring follows the rationale of the Mediterranean dietary pattern that suggests an intake of 15--30 g of ethanol per day. Higher values of this diet score indicate greater adherence to the Mediterranean diet (theoretical range 0--55), and have already been associated with CVD risk and markers \[[@B17]\].

2.7. Assessment of Depressive Symptoms {#sec2.7}
--------------------------------------

Clinical symptomatology of depression during the past month was determined by a specialised, confidential and weighted questionnaire, which was based on a self-reported depression scale (range 0--60) developed by Radloff, known as the Center of Epidemiological Studies-Depression scale (CES-D) and validated for the Greek population, by Fountoulakis et al. \[[@B18]\]. The aforementioned scale has been found a reliable and valid measure of depressive symptomatology \[[@B19]\]. Since no accurate cut-offs have been proposed for the Greek population the tertiles of the CES-D score were used to classify the patients. Thus, the participants were divided in three equal size categories (tertiles): (a) 1st tertile (CES-D \< 6), that represents rare symptoms, (b) 2nd tertile (18 \< CES-D \< 26), that represents moderate symptoms, and (c) 3rd tertile (CES-D \> 26), that represents more severe symptoms. The questions used for the evaluation of the investigated emotions are listed below: "How often during the past month you..." were bothering by things that usually do not bother you; had poor appetite; feeling that you could not shake off the blues even with help from your family; feeling of being just as good as other people; trouble keeping your mind on what you were doing; feeling that everything you did was an effort; feeling hopeful about your future; thought that your life had been a failure; feeling fearful; having restless sleep; being happy; talking less than usual; feeling lonely; considering people being unfriendly to you; enjoying your life; having crying spells; feeling sad; feeling that people disliked you; could not get "going".

2.8. Follow-Up of the Patients {#sec2.8}
------------------------------

The lost to follow up rate was 10% for the 30-days, re-evaluations. Patients lost to follow-up were considered as missing cases. The follow up of the patients included evaluation for vital status (death from CVD or other cause) and rehospitalization due to acute coronary syndrome (i.e., acute MI or unstable angina as defined above) or other cardiac symptoms (i.e., arrhythmias, stable angina).

2.9. Statistical Analysis {#sec2.9}
-------------------------

Power analysis (GPower 3.1.1, Germany) showed that the number of enrolled participants (*n* = 277) is adequate to evaluate a 0.05 change in the odds ratio of developing a 30-day adverse CVD event per 1-unit change in the CES-D score used, achieving statistical power equal to 98% at 5% significance level. Normally distributed continuous variables are presented as mean values ± standard deviation, skewed variables are presented as median and quartiles, while categorical variables are presented as relative (%) frequencies. Associations between normally distributed continuous variables and group of patients were evaluated through the Student\'s *t*-test, after controlling for equality of variances (homoscedacity) using the Levene test. The associations between skewed variables (i.e., Troponin I, BNP, glucose, triglycerides) and group of patients were evaluated through the Mann-Whitney test. Associations between categorical variables were evaluated by the use of the chi-squared test, without the correction of continuity. Correlations between continuous variables were evaluated by the use of Pearson\'s correlation coefficient for the normally distributed and by the Spearman\'s rho coefficient for the ordinal or skewed variables. Normality was evaluated through the Shapiro-Wilk test. The association between the MedDietScore and CES-D score with the occurrence of a CVD event was evaluated using multiple logistic regression analyses, after controlling for socio-demographic, clinical, and biochemical characteristics of the patients. Appropriate tests for goodness-of-fit (i.e., Hosmer-Lemeshow and deviance residuals) were applied in all models. Results are presented as odds ratios and their corresponding 95% confidence intervals. All statistical calculations will be performed on the SPSS version 18 software (SPSS Inc, Chicago, Il, USA).

3. Results {#sec3}
==========

The follow-up evaluation of the patients showed that 22% had a CVD event during the first 30-days following hospitalization (14.8% were re-hospitalised and 9.4% died). Regarding in-hospital mortality, 6% of the ACS patients died while hospitalized. There were no gender differences between those who developed an adverse cardiac event compared to the rest. In [Table 1](#tab1){ref-type="table"} clinical, biochemical and lifestyle characteristics of the patients who developed or not an adverse CVD during the 30-day followup are presented.

Moreover, patients in the upper tertile of the CES-D scale (i.e., \>18) had higher incidence of 30-day CVD events as compared with those in the lowest tertile (21% versus 8%, *P* = .01); in addition they were more likely to be females (48% versus 10%, *P* = .001), they had higher prevalence of hypertension (88% versus 63%, *P* = .05) and lower current smoking habits (27% versus 20%, *P* = .05), while no difference was observed according to diabetes mellitus history, physical activity status, dietary habits, BMI, left ventricular ejection fraction, and previous history of CVD.

In [Table 2](#tab2){ref-type="table"}, clinical, biochemical, and lifestyle characteristics of the patients who developed or not an adverse CVD during the 30-day followup by the tertile of the MedDietScore (\<16, 16--19, \>19) are presented. Among all tertiles of MedDietScore, those patients who presented an adverse cardiac event had lower prevalence of smoking habits, higher plasma BNP levels, higher prevalence of myocardial infarction than unstable angina, lower creatinine clearance levels, more advance age, higher CES-D score, higher diabetes mellitus prevalence, and lower left ventricular ejection fraction.

From the abovementioned results, it seems that a positive relationship between depression status and short-term prognosis of ACS patients exists. However, residual confounding may be present, since several clinical, lifestyle, and behavioural characteristics were associated with adherence to the depression status, as well as the prognosis of the patients. In addition, a significant interaction was observed between CES-D score and MedDietScore (*P* = .03); thus, the following analysis was stratified by dietary habits class (i.e., away, close, and very close to the Mediterranean diet). Multiadjusted analyses revealed that one-unit increase (1/60) in the Depression scale was associated with 4% higher odds of developing 30-day adverse cardiac event after discharge, controlling physical activity status, age, gender, BMI, smoking habits, history of hypertension, hypercholesterolemia, diabetes, first event of CVD, and left ventricular ejection fraction. When in the model the MedDietScore was entered, CES-D variable lost its significance, suggesting a strong mediating effect ([Table 3](#tab3){ref-type="table"}).

4. Discussion {#sec4}
=============

This study demonstrated that the relationship between depression and CVD development following an ACS in elderly patients is mediated by dietary habits. In particular, previous depression status was initially associated with the development of CVD events; however, when dietary habits were taken into account this relationship was lost. The findings were independent of several potential cofounders such as sex, age, ejection fraction of the left ventricle, body mass index, smoking habits, history of CVD, diabetes mellitus, hypercholesterolemia, hypertension, number of vessel disease, revascularization, and physical activity status.

Previous studies have shown that even minor elevations in depressive symptoms (subthreshold depression, defined to include mood, somatic, and interpersonal symptoms of depression, but not necessarily a diagnosable depressive disorder) significantly increase the risk of incidence of CHD among previously healthy participants or worsen the cardiac prognosis in patients with established CHD \[[@B10]--[@B21]\]. The scientific evidence is strongest for patients who have been hospitalized for an ACS, that is, MI or unstable angina \[[@B22]\]. Similarly, according to the GREECS study, which included 2172 patients with ACS, the short-term depressive symptoms are related to more severe disease and a worsen 30-day prognosis of patients hospitalized for ACS \[[@B23]\].

Despite the consistency of the findings in these reviews, it remains unclear why a number of individual studies with robust methodologies have failed to show an adverse effect of depression on mortality especially among the elderly \[[@B24], [@B25]\]. Furthermore, psychological interventions have failed to show a reduction in mortality, which would be expected if depression caused an increase in mortality \[[@B26]\]. The conflicting results of previous studies may be attributable to the way depression is measured, because different measures may be sensitive to different dimensions of depression, or duration of followup \[[@B10]\]. Furthermore, variation in timing of the assessments and variable attempts to control for the confounding effect of severity of heart disease may be also responsible for the heterogeneity \[[@B27]\]. However, what are less established are the mechanisms responsible for the effect of depression on cardiovascular risk \[[@B28]\]. It has been reported that depression might increase CHD incidence and mortality by promoting factors associated with coronary atherosclerosis. The effect of depressive symptoms may be direct, inducing cardiac ischemia, increasing the risk for cardiac arrhythmias and sudden death, increasing the levels of blood lipids, platelets, and inflammatory factors, as well as indirect by promoting unhealthy behaviours, like cigarette smoking, decreased adherence to medications, physical inactivity, poor, unhealthy diet, and other lifestyle characteristics \[[@B29]\]. Especially for the prognosis of CHD patients, van Melle et al. \[[@B30]\] reported that among myocardial infarction survivors, the rate of depression and the severity of depressive symptoms were significantly related to the severity of left ventricular dysfunction, giving a potential pathophysiological mechanism for the prognosis of patients with depressive symptoms. Moreover, Carney et al. \[[@B31]\] suggested that the dys-regulation of the autonomic nervous system may partially mediate the increased risk for mortality in depressed myocardial infarction patients with frequent ventricular contractions. Furthermore, depression is associated with poor secondary prevention among patients who have had an acute ischemic event. In the large Heart and Soul study \[[@B32]\] of patients with depression and CHD, an association between depressive symptoms and adverse cardiovascular events was largely explained by behavioral factors, especially physical inactivity. It is also illustrated in other studies that unhealthy behaviors accompany depressive symptomatology and can mainly explain the occurrence of adverse cardiovascular events \[[@B33]\].

In the present work, when MedDietScore, that evaluates the level of adherence to a healthy dietary pattern, was included in the analysis, the depression variable lost its significant for the occurrence of adverse cardiac events during the short-term followup. Additionally, the 30-day outcome was inversely related to MedDietScore. The possible cardioprotective effects of Mediterranean diet became widely known for the first time in the 1970s from the Seven Countries Study \[[@B7]\]. Since then, there are numerous indications that adoption of a Mediterranean diet is associated with decreased all-cause mortality and improvements in cardiovascular risk factors levels \[[@B34], [@B35]\] due to the diet\'s antithrombotic, anti-inflammatory, and antioxidant effects \[[@B36], [@B37]\]. Among those studies, the HALE project revealed the protective effect of Mediterranean type of diet on cardiovascular and total mortality in elderly individuals \[[@B38]\]. It is known that inflammation and oxidative stress accompany the clinical presentation and course of an ACS, affecting infarct size. Infarct size determines postinfarction survival and prognosis, as it is the most important factor of ventricular remodelling process and left ventricular systolic function. Olive oil, which is the main source of fat in the Mediterranean type of diet, is rich in oleuropein, which has been shown to reduce the infarct size, in experimental models \[[@B39], [@B40]\], and also to protect reperfused myocardium from oxidative damage "in vivo," resulting in more preserved left ventricular systolic function \[[@B41]\]. In a recent study \[[@B9]\], it was revealed that ACS patients that had closer adherence to the Mediterranean diet preserved left ventricular systolic function, while they showed less in-hospital deaths and cardiovascular events during the two-years of followup. These findings were unaltered after controlling for several patient characteristics, like lifestyle behaviours, medical history as well as biological factors at hospital admission. Those cardioprotective mechanisms of Mediterranean diet might modify beneficially the adverse effects of depression symptomatology on cardiovascular system.

5. Limitations {#sec5}
==============

The present work has several strengths mentioned above, but also some limitations. For example, only survivors of ACS were studied. Thus, there is no information from patients who died during the first two days of hospitalization (approximately 2% of the total hospitalizations). For the dietary evaluation, a holistic dietary approach using food patterns (i.e., Mediterranean diet) and not single food approach was used. The rationale of this approach was that overall diet assessment represents a broader picture of food and nutrient consumption of real life. Furthermore, dietary patterns capture the extremes of dietary habits, preempts nutritional confounding, possible effect modification among nutritional variables through the same procedure, and they do not tend to be biased.

6. Conclusion {#sec6}
=============

This study highlights the effectiveness of adhering to the Mediterranean diet on cardiac events following ACS, especially for elderly individuals with depression. Regardless of any drug treatment prescribed, clinicians should routinely advise patients with acute coronary syndromes to increase their frequency of consumption of Mediterranean foods, as it seems that this type of diet can attenuate the adverse effects of depression on cardiovascular health. Further studies are needed to investigate the most effective way to treat patients suffering from depressive symptoms and convince them to follow more healthy dietary patterns and a healthy lifestyle in general.
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###### 

Clinical, biochemical, and lifestyle characteristics of ACS elderly patients (*n* = 277), according to the development of 30-day CVD events.

                                 30-day CVD event   Free of 30-day CVD event   *P*-value
  ------------------------------ ------------------ -------------------------- -----------
  *N*, (%)                       61 (22)            216 (78)                   
  Age (yrs)                      76 ± 6             74 ± 6                     .036
  Gender (%male)                 69                 70                         .82
  Body mass index (kg/m^2^)      26.7 ± 5.2         28 ± 5                     .197
                                                                               
  Hospital admission variables                                                 
                                                                               
  MI (%)                         85                 67                         .001
  First CVD event (%)            52%                56%                        .672
  Ejection Fraction (%)          33                 44                         .001
  Revascularization (%)          33%                27%                        .347
  Creatinine Clearance (mL)      49.22 ± 23         60.2 ± 22                  .003
  Troponin I (ng·mL)             10.22 ± 22         8.3 ± 2.1                  .56
  Glucose levels (mg/dL)         189.5 ± 118.7      161 ± 79.4                 .034
  BNP (pg/mL)                    943 ± 148          475 ± 66                   .005
                                                                               
  Medical history variables                                                    
                                                                               
  CES- scale (0--60)             34.20 ± 18.44      22.68 ± 12.5               .007
  Physical active (%)            51%                59%                        .376
  Smoking current (%)            31%                30%                        .865
  Hypercholesterolaemia (%)      71%                53%                        .013
  Hypertension (%)               71%                72%                        .901
  Diabetes mellitus (%)          45%                41%                        .551
  MedDietScore                   17.5 ± 4           18.1 ± 4                   .05
  Systolic blood pressure        125 ± 29           134 ± 24                   .064

###### 

Clinical, biochemical, and lifestyle characteristics of ACS elderly patients (*n* = 277), according to the development of 30-day CVD events and their dietary habits.

                                 MedDietScore (0--55)                                                                                   
  ------------------------------ ---------------------- --------------- ------ ------------- ----------- ------ ----------- ----------- ------
  *N*, %                         31                     78                     8             75                 22          63          
  Age (yrs)                      77 ± 6                 76 ± 6          .731   76 ± 6        75 ± 6      .707   75 ± 6      75 ± 5      .767
  Gender (%male)                 57                     59              .918   35            38.5        .632   34.5        46          .003
                                                                                                                                        
  Hospital admission variables                                                                                                          
                                                                                                                                        
  MI (%)                         95                     74              .001   50            61          .745   60          74          .458
  First CVD event (%)            43                     50              .664   50            39          .745   40          56          .425
  Ejection Fraction (%)          34.5                   35              .822   57.53.6       56.6 ± 23   .859   65 ± 25     63 ± 19     .817
  Revascularization (%)          42                     23              .229   25            18          .807   50          52          .925
  Creatinine Clearance (mL)      41.37 ± 24.94          58.36 ± 24.74   .044   50            76          .444   80          81          .924
  Troponin I (ng·mL)             6.71 ± 9.77            10.57 ± 21.6    .415   9.5 ± 13      6.67 ± 17   .751   12.4 ± 27   9.9 ± 28    .819
  BNP (pg/mL)                    1089 ± 1043            642 ± 714       .241   1460 ± 1045   629 ± 870   .453   744 ± 440   375 ± 490   .09
                                                                                                                                        
  Medical history variables                                                                                                             
                                                                                                                                        
  CES- scale (0--60)             21 ± 24                19 ± 9          .947   34 ± 19       25 ± 15     .924   41 ± 20     31 ± 13     .467
  BMI (kg/m^2^)                  25.4 ± 3.2             27.5 ± 3.7      .057   33 ± 7.5      26.9 ± 4    .295   27 ± 4      28.5 ± 9    .487
  Physical active (%)            36                     47              .482   67            61          .875   70          70          .984
  Smoking current (%)            14                     32              .164   67            33          .424   30          30          .984
  Hypercholesterolaemia (%)      57                     53              .808   67            55          .755   80          65          .384
  Hypertension (%)               64                     62              .238   100           69          .001   70          70          .984
  Diabetes mellitus (%)          43                     53              .541   67            48          .645   60          33          .176

###### 

Results from additive logistic regression models that evaluated the association of CES-D score on the likelihood of developing 30-day CVD events among *n* = 277 elderly ACS survivors.

                                    OR (95% CI)            OR (95% CI)            OR (95% CI)
  --------------------------------- ---------------------- ---------------------- ----------------------
  CES-D (per 1/60 units)            1.011 (0.98--1.046)    1.042 (1.008--1.076)   1.025 (0.987--1.065)
  First coronary event (Y/N)        0.909 (0.43--1.889)    0.505 (0.210--1.217)   0.63 (0.234--1.693)
  Age (per 1 year)                  1.015 (0.985--1.045)   1.018 (0.946--1.096)   0.987 (0.908--1.072)
  Male versus female gender         1.118 (0.495--2.524)   0.568 (0.224--1.438)   0.731 (0.258--2.067)
  Revascularization (Y/N)           ---                    2.453 (0.97--6.305)    2.477 (0.866--7.086)
  Physical activity (Y/N)           ---                    1.138 (0.476--2.723)   0.868 (0.325--2.318)
  Current smoking habits (Y/N)      ---                    0.668 (0.23--1.941)    0.688 (0.215--2.202)
  Body Mass Index (per 1 kg/m^2^)   ---                    0.946 (0.853--1.048)   0.961 (0.866--1.067)
  Hypercholesterolemia (Y/N)        ---                    1.869 (0.762--4.586)   1.246 (0.46--3.37)
  Hypertension (Y/N)                ---                    0.983 (0.378--2.551)   0.876 (0.294--2.604)
  Diabetes mellitus (Y/N)           ---                    1.009 (0.432--2.354)   1.139 (0.428--3.033)
  Ejection fraction (per 1%)        ---                    0.935 (0.897--0.975)   0.951 (0.903--1.001)
  MedDietScore (per 1/55 units)     ---                    ---                    0.989 (0.866--1.130)
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